Market Overview - A-shares saw a collective rise, with the Sci-Tech Innovation Board leading with over 3% increase [1] - The total trading volume in Shanghai, Shenzhen, and Beijing reached 2.62 trillion yuan, a decrease of 180.4 billion yuan from the previous day [1] Sector Performance - The semiconductor sector experienced significant gains, with the electronic sector attracting a net inflow of 39.254 billion yuan, the highest among 31 primary industries [1] - Precious metals saw gold prices surpassing 4,800 USD for the first time, leading the non-ferrous metals sector to outperform the market, with five stocks hitting the daily limit [1][3] - The electronic ETF (515260) surged by 3.13%, while the non-ferrous ETF (159876) rose by 3.01%, both reaching historical highs [2][3] AI and Technology Trends - The AI narrative remains strong, with expectations for sustained high demand in computing hardware, particularly in the domestic AI industry chain [1] - The Sci-Tech Artificial Intelligence ETF (589520) saw a price increase of 2.69%, with a net inflow of 150 million yuan over the past ten days [1] - The market consensus indicates that CPO (Chiplet Packaging Option) is becoming a necessary technology, with rapid growth expected in 800G and 1.6T optical modules by 2026 [1] Investment Opportunities - The non-ferrous ETF (159876) has seen significant capital inflow, with a net subscription of 18.6 million units and a total of 635 million yuan over the past ten days [4] - The healthcare sector is experiencing a boost due to new policies from the National Medical Insurance Administration, which are expected to enhance innovation and profitability in high-end medical devices and robotic surgeries [18][19] - The Hong Kong medical ETF (159137) rose by 1.06%, ending a four-day decline, with significant gains in leading medical stocks [16][19]

Core Viewpoint - The new policy from the National Healthcare Security Administration (NHSA) is expected to significantly boost the medical device industry, particularly benefiting high-end surgical assistance technologies, robotic surgeries, and telemedicine [1][3]. Group 1: Market Reaction - A-share medical ETFs, particularly the largest medical ETF (512170), saw a rise of 1.36% during intraday trading, indicating strong buying interest with over 270 million yuan invested the previous day [1]. - The Hong Kong medical ETF (159137) also experienced a rebound, reaching a peak increase of 1.78% before closing up 1.06%, ending a four-day decline [1]. - Notable stock performances included a 17.3% surge in the leading domestic surgical robot company, MicroPort Scientific Corporation-B, and over 5% increases in MicroPort Medical and Xianjian Technology [1]. Group 2: Policy Impact - The NHSA's new guideline establishes a market mechanism for high-end surgical assistance technologies, which is expected to enhance innovation and profitability in the industry [3]. - The unified pricing framework is anticipated to highlight the cost-performance advantages of domestic surgical robots and related consumables, accelerating the trend of domestic substitution [3]. - The NHSA's commitment to expanding the guideline in the future will create more opportunities for innovative medical device products, benefiting the overall innovation ecosystem in the industry [3]. Group 3: Investment Opportunities - The medical device sector is poised for significant investment opportunities due to the new NHSA policy, with a focus on high-end medical equipment, robotic surgeries, and compliant consumables [3]. - The CXO industry is experiencing improved conditions due to recovering overseas orders and domestic capacity clearance, contributing to sustained growth [3]. - The largest medical ETF (512170) and its associated funds focus on medical devices and services, with over 36% of its index weight in AI medical and brain-computer interface concept stocks [4].

1月21日，恒生指数收涨0.37%，恒生科技指数涨1.11%。 | 代码 | 名称 | 现价 | 涨跌 | 涨跌幅 | 成交额 | | --- | --- | --- | --- | --- | --- | | HSI | 恒生指数 | 26585.06c | 97.55 | 0.37% | 2505亿 | | HSTECH | 恒生科技 | 5746.30c | 62.86 | 1.11% | 662亿 | | HSBIO | 恒生生物科技 | 15873.73c | 130.76 | 0.83% | 101亿 | | HSCEI | 恒生中国企业指数 | 9122.95c | 28.19 | 0.31% | 888亿 | | HSCI | 恒生综合指数 | 4097.20c | 21.38 | 0.52% | 1686亿 | 科网股集体反弹，华虹半导体涨逾5%，商汤涨超4%， 同程旅行、 中芯国际、快手、 百度集团、阿里 健康涨逾3%，阿里巴巴、比亚迪股份、哔哩哔哩等均走高。 | 名称 | 现价 | 涨跌 | 涨跌幅, | 成交额 | | --- | --- | --- | --- | --- | | 花 ...

1月21日，恒生指数收涨0.37%，恒生科技指数涨1.11%。 | 代码 | 名称 | 现价 | 涨跌 | 涨跌幅 | 成交额 | | --- | --- | --- | --- | --- | --- | | HSI | 恒生指数 | 26585.06c | 97.55 | 0.37% | 2505亿 | | HSTECH 恒生科技 | | 5746.30c | 62.86 | 1.11% | 662亿 | | HSBIO | 恒生生物科技 | 15873.73c | | 0.83% | 101亿 | | HSCEI | | 恒生中国企业指数 9122.95c | 28.19 | 0.31% | 888亿 | | HSCI | 恒生综合指数 | 4097.20c | 21.38 | 0.52% | 1686亿 | 科网股集体反弹，华虹半导体涨逾5%，商汤涨超4%， 同程旅行、 中芯国际、快手、 百度集团、阿里健康涨逾3%，阿里巴巴、比亚迪股份、哔哩哔哩 等均走高。 机器人股走强，微创机器人涨超17%，卧安机器人涨超10%，越疆涨超9%。 | 微创机器人-B | 30.920 | 17.30% | | --- ...

Group 1 - The Hang Seng Tech Index experienced a significant increase, with a peak rise of 1.7% [1] - Notable individual stocks included Kuaishou and Hua Hong Semiconductor, both rising over 5% [1] - Baidu Group and Tongcheng Travel saw increases of over 4%, while SMIC and Alibaba Health rose over 3% [1] Group 2 - Alibaba, BYD Electronics, Bilibili, Sunny Optical, and BYD Company all recorded gains exceeding 2% [1]

Core Viewpoint - The National Healthcare Security Administration (NHSA) is promoting the transformation of precision medicine, leading to a strong performance in the medical sector of both A-shares and Hong Kong stocks on January 21 [1][7]. Group 1: Market Performance - In the Hong Kong market, MicroPort Scientific Corporation (MicroPort) surged over 12%, leading the gains, while Alibaba Health increased by over 3% [1][7]. - The Hong Kong medical ETF, Huabao (159137), reached a peak of 1.78% during trading [1][7]. - A-shares also saw a recovery, with Meiyuan Health and Kingmed Diagnostics rising over 3%, and Yuyue Medical and Yingke Medical both increasing over 2% [3][9]. Group 2: ETF Insights - The largest medical ETF in the market (512170) rose over 1.3%, recovering its six-month moving average, with significant capital inflow of over 270 million yuan in net subscriptions [3][9]. - As of January 20, 2026, the medical ETF fund size is 26 billion yuan, making it the largest among medical ETFs in the market [5][11]. Group 3: Policy Developments - The NHSA issued the "Guidelines for the Pricing of Surgical and Treatment Auxiliary Medical Services (Trial)," standardizing pricing for robotic surgeries and remote surgical assistance [5][11]. - The guidelines include 37 pricing items, 5 additional charges, and 1 expansion item, covering various fields such as 3D reconstruction and remote surgery [5][11]. - Notable highlights in pathology services include the establishment of a separate pricing item for pathology diagnosis and the inclusion of digital pathology slice storage in the pricing structure [5][11].

1月21日早盘，港股医疗板块盘初下探后持续走强。截至10:29，中证港股通医疗主题指数上涨1.4%，成 分股中，微创机器人-B涨超12%，微创医疗涨超4%，阿里健康涨超3%。 消息面上，在2026年1月举办的J.P. Morgan医疗健康大会上，全球药企密集披露前沿研发管线与大额BD 交易，为CXO行业带来明确订单预期。与此同时，AI医疗在C端的渗透正在加速，从智能问诊到慢病管 理的应用场景不断拓展，推动阿里健康、京东健康等港股互联网医疗平台价值重估。 有分析指出，当前医疗板块具备多重投资机会。CXO行业在海外订单回暖和国内产能出清的双重推动 下，景气度持续提升且估值仍具修复空间；医疗器械领域受益于国内设备更新政策支持与海外市场拓 展，脑机接口、AI影像等前沿方向催化不断；互联网医疗则在医保支付改革深化背景下，平台运营效 率持续优化，盈利增长曲线愈发清晰。 中证港股通医疗主题指数从港股通证券范围内选取50只业务涉及医疗器械、医疗商业与服务、制药与生 物科技服务等领域的股票作为指数样本，重点覆盖CXO与互联网医疗等港股特色标的。港股通医疗ETF 易方达（520850）跟踪该指数，可助力投资者精准把握医疗产业创新 ...

Core Viewpoint - Alibaba Health (00241) has seen a stock increase of over 4%, currently trading at 6.86 HKD with a transaction volume of 532 million HKD, following the news of its AI product "Hydrogen Ion" completing internal testing and being available for download [1] Group 1: Product Development - The AI product "Hydrogen Ion" is now in the practical application phase, targeting doctors in clinical and research fields [1] - "Hydrogen Ion" emphasizes "low hallucination, high evidence" capabilities, ensuring all responses have authoritative sources and support one-click traceability to the original source [1] Group 2: User Feedback - Multiple doctors involved in the internal testing have reported that "Hydrogen Ion" demonstrates high accuracy in evidence-based Q&A, evidence integration, and analysis summarization tasks [1] - The product is particularly effective in intelligent retrieval and literature review in both Chinese and English, aligning well with the habits of domestic doctors [1] Group 3: Market Positioning - The product logic of "Hydrogen Ion" is similar to the popular overseas product OpenEvidence, but it offers a more localized experience, providing a competitive advantage in the domestic market [1]

Core Viewpoint - Alibaba Health's AI product "Hydrogen Ion" has completed internal testing and is now available for download, targeting clinical and research doctors, aiming to be the AI assistant with the lowest hallucination rate in the medical field [1] Group 1: Product Launch and Features - The "Hydrogen Ion" product emphasizes "low hallucination, high evidence" capabilities, providing authoritative sources for all answers and supporting one-click traceability to the original sources [1] - Feedback from multiple doctors involved in the internal testing indicates that "Hydrogen Ion" demonstrates high accuracy in evidence-based Q&A, evidence integration, and analysis, particularly in intelligent retrieval and literature review in both Chinese and English [1] Group 2: Market Positioning - The product logic of "Hydrogen Ion" is similar to the popular overseas product OpenEvidence, but it offers a more localized experience that better suits the habits of domestic doctors [1]

Market Overview - On January 21, the Hang Seng Index opened down by 0.34%, while the Hang Seng Tech Index fell by 0.70% [1] - The current value of the Hang Seng Index is 26,397.04, down by 90.47 points, representing a decrease of 0.34% [2] - The Hang Seng Tech Index is at 5,643.62, down by 39.82 points, reflecting a decline of 0.70% [2] Sector Performance - Hardware, machinery, media, and semiconductor sectors experienced the largest declines, while sectors such as non-ferrous metals, home appliances, banking, and electrical equipment showed gains [2] - Notable declines in tech stocks include Bilibili and SenseTime, both down over 2%, and companies like Trip.com, Xiaomi, SMIC, Kuaishou, and Xpeng all falling more than 1% [2] Individual Stock Movements - Bilibili (9626.HK) is trading at 236.80, down by 2.87% [3] - SenseTime (0020.HK) is at 2.33, down by 2.10% [3] - Xpeng Motors (9868.HK) is priced at 78.15, down by 1.70% [3] - SMIC (0981.HK) is at 73.45, down by 1.41% [3] - Kuaishou (1024.HK) is trading at 75.20, down by 1.12% [4] - Xiaomi Group (1810.HK) is at 35.10, down by 1.07% [4] - Alibaba (9988.HK) is priced at 158.30, down by 0.88% [4] - Tencent Holdings (0700.HK) is at 598.00, down by 0.50% [4] Gold Sector Performance - The gold sector showed strong performance, with Datang Gold rising over 11%, Lingbao Gold up over 6%, and Zhaojin Mining increasing by over 3% [5]